Rxo Inc (RXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,421,000 | 1,419,000 | 1,433,000 | 1,667,000 | 1,040,000 |
| Cost of Goods | 1,185,000 | 1,165,000 | 1,201,000 | 1,407,000 | 858,000 |
| Gross Profit | 236,000 | 254,000 | 232,000 | 260,000 | 182,000 |
| Operating Expenses | 243,000 | 254,000 | 262,000 | 284,000 | 202,000 |
| Operating Income | -7,000 | N/A | -30,000 | -24,000 | -20,000 |
| Interest Expense | 9,000 | 8,000 | 9,000 | 8,000 | 6,000 |
| Other Income | 1,000 | -2,000 | 0 | -1,000 | -216,000 |
| Pre-tax Income | -15,000 | -10,000 | -39,000 | -33,000 | -242,000 |
| Income Tax | -1,000 | -1,000 | -8,000 | -8,000 | 1,000 |
| Net Income Continuous | -14,000 | -9,000 | -31,000 | -25,000 | -243,000 |
| Net Income | $-14,000 | $-9,000 | $-31,000 | $-25,000 | $-243,000 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.18 | -0.17 | -1.81 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.18 | -0.17 | -1.81 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.18 | -0.17 | -1.81 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.18 | -0.17 | -1.81 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.04 | -0.03 | 0.06 | 0.05 |
| EBITDA(a) | $19,000 | $30,000 | $2,000 | $9,000 | $1,000 |